BHST
BioHarvest Sciences, Inc.
NASDAQ · Basic Materials · Agricultural Inputs · CA
$1.48
−3.90%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$1.53
From 52W high−83.28%
Volume5203.00
Market cap$33.55M
P/E (TTM)—
P/S (TTM)0.9x
Div yield—
Key dataNov 4, 2026
Open
$1.53
From 52W high
−83.28%
Volume
5203.00
Market cap
$33.55M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−4.8x
P/E (TTM)
—
RSI (14)
39.4
MomentumView details →
1D Return
−3.90%
YTD Return
−70.71%
SummaryUpdated Jun 1, 2026
BioHarvest Sciences Inc. (NASDAQ:BHST) is a Canadian biotechnology company founded to revolutionize how botanical compounds are produced for nutraceutical and pharmaceutical applications. Based in Vancouver, Canada, with operations in Israel and the United States, the company has developed a proprietary botanical synthesis platform that enables the cultivation of plant cells in bioreactors rather than traditional farming methods. Since completing its NASDAQ uplisting in 2024, BioHarvest has positioned itself as both a direct-to-consumer wellness brand and a contract development and manufacturing organization (CDMO) serving pharmaceutical and food industry clients.
Similar companies
Latest newsMore news →
BioHarvest Sciences announced that it will report its third-quarter 2026 financial results before the market opens on November 12, 2026, and host a conference call and webcast at 8:00 a.m. Eastern Time.6d agoBioHarvest Sciences said Olive Cell, an olive-derived plant-cell ingredient, is ready for commercial licensing after completing large-scale bioreactor scale-up, manufacturing readiness and a self-affirmed U.S. GRAS process.22d ago